ITBG990061A1 - THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. - Google Patents
THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. Download PDFInfo
- Publication number
- ITBG990061A1 ITBG990061A1 IT1999BG000061A ITBG990061A ITBG990061A1 IT BG990061 A1 ITBG990061 A1 IT BG990061A1 IT 1999BG000061 A IT1999BG000061 A IT 1999BG000061A IT BG990061 A ITBG990061 A IT BG990061A IT BG990061 A1 ITBG990061 A1 IT BG990061A1
- Authority
- IT
- Italy
- Prior art keywords
- therapeutic
- present
- animal
- percentages
- ointment
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 12
- 230000002421 anti-septic effect Effects 0.000 title claims description 8
- 230000001225 therapeutic effect Effects 0.000 title claims description 6
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 239000002674 ointment Substances 0.000 claims description 8
- 210000004207 dermis Anatomy 0.000 claims description 6
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 4
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- 241000366182 Melaleuca alternifolia Species 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 229940099367 lanolin alcohols Drugs 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 2
- PSMFFFUWSMZAPB-UHFFFAOYSA-N Eukalyptol Natural products C1CC2CCC1(C)COCC2(C)C PSMFFFUWSMZAPB-UHFFFAOYSA-N 0.000 claims description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims 1
- 235000019271 petrolatum Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930006978 terpinene Natural products 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 241000378467 Melaleuca Species 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- -1 terpene alcohols Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
DESCRIZIONE DESCRIPTION
Questa invenzione si riferisce ad un unguento ad azione terapeutica ed antisettica del derma animale, particolarmente a localizzazione podalica. This invention refers to an ointment with therapeutic and antiseptic action of the animal dermis, particularly with breech localization.
Come è noto, gli animali domestici e/o da allevamento sono soggetti a ferirsi per una pluralità di cause usuali, tra le quali quelle derivanti da operazioni di mascalcia. Essendo l’animale un qualcosa di prezioso sia per ragioni affettive, sia per ragioni economiche, è importante che sue eventuali ferite guariscano in fretta e non creino complicazioni patologiche. A volte può essere addirittura importante proteggerlo in modo preventivo, con prodotti idonei a garantire un’igienicità o disinfezione di certe parti del suo corpo. Attualmente sono disponibili sul mercato, per tale impiego, vari tipi di disinfettanti. Essi sono tuttavia generalmente formulati secondo specifiche finalità; esistono cioè, dei disinfettanti che sono efficaci contro certi agenti patogeni, ma inutili nei confronti di altri agenti, cosicché l'impiego di essi può creare l’inconveniente tipico dei disinfettanti a bersaglio mirato, ovvero di risultare inefficaci. Inoltre, la generalità dei disinfettanti è prodotta per sintesi e, spesso, è fonte di fenomeni allergici e/o patologici collaterali. La possibilità, peraltro, di impiegare dei prodotti lenitivi, che attenuino il disagio dell’animale ferito, non sempre è associabile ad altri prodotti curativi o disinfettanti. Specialmente nel caso delle bovine da latte, poi, si ha la necessità dì lavare spesso l'animale o parti di esso; ne consegue che l’eventuale disinfettante posto su delle ferite di esso verrebbe rapidamente rimosso, specialmente se la ferita interessasse le zone dei suoi zoccoli o delle sue zampe. I battericidi attualmente usati, hanno spesso dei principi attivi basati sull’azione di antibiotici dagli effetti collaterali indesiderati non sempre conoscibili, giacché si estrinsecano in tempi molto lunghi ed in patologie che solo con grandi sperimentazioni (non sempre economicamente possibili) potrebbero essere riconducibili all’uso di tali antibiotici. Ciò può significare, per esempio, che la notevole attenzione veterinaria rivolta usualmente alle mucche da latte, rende assai probabile la presenza in esse di altri antibiotici, che potrebbero determinare pericolose reazioni anafilattiche. In ogni caso, considerando che dette sostanze antibiotiche sono, di fatto, in circolo nell’organismo delle bovine da latte in argomento, si può ben comprendere la possibilità che esse possano trasferire tali pericolose sostanze anche nel latte da esse prodotto. As is known, domestic and / or farm animals are subject to injury for a plurality of usual causes, including those deriving from farriery operations. Since the animal is something precious both for emotional and economic reasons, it is important that any wounds heal quickly and do not create pathological complications. Sometimes it may even be important to protect him in a preventive manner, with products suitable for ensuring hygiene or disinfection of certain parts of his body. Various types of disinfectants are currently available on the market for this use. However, they are generally formulated according to specific purposes; that is, there are disinfectants that are effective against certain pathogens, but useless against other agents, so that the use of them can create the typical drawback of targeted-target disinfectants, or of being ineffective. Furthermore, most of the disinfectants are produced by synthesis and are often the source of allergic and / or pathological collateral phenomena. The possibility, however, of using soothing products, which alleviate the discomfort of the injured animal, is not always associated with other curative or disinfectant products. Especially in the case of dairy cows, then, it is necessary to wash the animal or parts of it often; it follows that any disinfectant placed on its wounds would be quickly removed, especially if the wound affected the areas of its hooves or paws. The bactericides currently used often have active ingredients based on the action of antibiotics with undesirable side effects that are not always known, since they manifest themselves in a very long time and in pathologies that only with large trials (not always economically possible) could be traced back to use of such antibiotics. This may mean, for example, that the considerable veterinary attention usually paid to dairy cows makes it very likely the presence of other antibiotics in them, which could cause dangerous anaphylactic reactions. In any case, considering that said antibiotic substances are, in fact, circulating in the organism of the dairy cows in question, it is possible to understand the possibility that they can transfer these dangerous substances even in the milk they produce.
Scopo della presente invenzione è quello di definire un prodotto idoneo a svolgere una efficace azione terapeutica ed antisettica sul derma, degli animali in genere, che sia dotato di un ampio spettro d'azione. Altro scopo è quello di definire un prodotto, come sopra, che possa basarsi su principi attivi di origine naturale. Altro scopo è quello di definire un prodotto, come sopra, che sia associabile a fattori idonei a lenire la sofferenza dell’animale. Altro scopo è quello di definire un prodotto, come sopra, che possa essere applicato al derma dell’animale e permanervi a lungo anche in caso di lavaggio. Questi ed altri scopi appariranno come raggiunti dalla lettura della descrizione seguente, illustrante un unguento ad azione terapeutica ed antisettica del derma animale, particolarmente per l'igiene e la salute dei piedi degli ungulati, avente la particolarità di trarre proprietà antisettiche ad ampio spettro, in prevenzione ed in terapia, dall’impiego di un olio essenziale ottenuto per distillazione in corrente di vapore acqueo del fogliame della pianta Melaleuca Alternifolia con contenuti minimi in Terpinen-4-OL del 35% e con contenuti massimi in 1 ,8 Cineolo del 5%, detto olio essendo presente in percentuali variabili dal 0,5 al 5% in una formulazione comprendente: - agenti idratanti costituiti da alcoli di Lanolina presenti in percentuali variabili dal 10 al 20%; The purpose of the present invention is to define a product suitable for carrying out an effective therapeutic and antiseptic action on the dermis of animals in general, which is endowed with a broad spectrum of action. Another purpose is to define a product, as above, which can be based on active ingredients of natural origin. Another purpose is to define a product, as above, that can be associated with factors suitable for alleviating the suffering of the animal. Another purpose is to define a product, as above, that can be applied to the animal's dermis and remain there for a long time even in case of washing. These and other purposes will appear as achieved by reading the following description, illustrating an ointment with a therapeutic and antiseptic action of the animal dermis, particularly for the hygiene and health of the feet of ungulates, having the particularity of obtaining broad-spectrum antiseptic properties, in particular prevention and therapy, from the use of an essential oil obtained by steam distillation of the foliage of the Melaleuca Alternifolia plant with minimum contents in Terpinen-4-OL of 35% and with maximum contents in 1, 8 Cineole of 5% , said oil being present in percentages ranging from 0.5 to 5% in a formulation comprising: - moisturizing agents consisting of lanolin alcohols present in percentages ranging from 10 to 20%;
- veicolanti lipidici costituiti da olii di vaselina presenti in percentuali variabili dal 65 all'80%; - lipid carriers consisting of vaseline oils present in percentages ranging from 65 to 80%;
- fattori di consistenza costituiti da alcoli grassi di buona tecnologia del settore presenti in percentuali variabili dal 5 al 10%; - consistency factors consisting of fatty alcohols of good technology in the sector present in percentages ranging from 5 to 10%;
- fattore lenitivo ed anti-arrossamento costituito da bisabololo in una percentuale variabile massima deN’1 %. L’olio di Melaleuca di cui sopra è estratto per distillazione in corrente di vapore acqueo del fogliame della Melaleuca Alternifolia. Esso è composto da una miscela di monoterpeni, sesquiterpeni ed alcoli terpenici in cui il contenuto in TERPINEN-4-OL non è inferiore al 30% per svolgere la migliore azione germicida ed il contenuto in 1 ,8 CINEOLO non supera il 15%, per non generare irritazione delle mucose. La percentuale massima del TERPINEN-4-OL, oltre la quale non aumenta il potere battericida, è del 40%. Tra gli altri componenti importanti presenti nel citato olio (che ne comprende oltre 90) sono citabili: - soothing and anti-redness factor consisting of bisabolol in a maximum variable percentage of 1%. The aforementioned Melaleuca oil is extracted by steam distillation of the foliage of Melaleuca Alternifolia. It is composed of a mixture of monoterpenes, sesquiterpenes and terpene alcohols in which the content in TERPINEN-4-OL is not less than 30% to perform the best germicidal action and the content in 1, 8 CINEOL does not exceed 15%, for do not generate irritation of the mucous membranes. The maximum percentage of TERPINEN-4-OL, beyond which the bactericidal power does not increase, is 40%. Among the other important components present in the aforementioned oil (which includes over 90), the following can be mentioned:
a - terpineol, in quantità variabili dal 1 ,5 al 8%; a - terpineol, in quantities ranging from 1.5 to 8%;
τ - terpinene, in quantità variabile dal 10 al 28%; τ - terpinene, in quantities ranging from 10 to 28%;
a - terpinene, in quantità variabile dal 5 al 13%; a - terpinene, in quantities ranging from 5 to 13%;
p- cymene, in quantità variabile dal 0,5 al 12%. p-cymene, in quantities ranging from 0.5 to 12%.
Tale olio è presente nell’unguento di cui all’invenzione in una percentuale variabile dal 0,5 al 5% dipendentemente dal potere disinfettante richiesto. Nel citato unguento sono presenti, in una percentuale variabile dal 65 all'80% degli olii di vaselina con funzione di veicolanti lipidici. Quali agenti idratanti ed emollienti sono invece presenti in una percentuale compresa tra il 10 ed il 20% degli alcoli di Lanolina. Per regolare il grado di viscosità dell’unguento vengono impiegati degli alcoli grassi in percentuali variabili dal 5 al 10%. This oil is present in the ointment referred to in the invention in a variable percentage from 0.5 to 5% depending on the required disinfectant power. In the aforementioned ointment are present, in a variable percentage from 65 to 80% of vaseline oils with the function of lipid carriers. As moisturizing and emollient agents, on the other hand, they are present in a percentage between 10 and 20% of Lanolin alcohols. To regulate the degree of viscosity of the ointment, fatty alcohols are used in percentages ranging from 5 to 10%.
A tale miscela potrebbe essere associato del Bisabololo in una percentuale massima del 1 % per far svolgere all'unguento anche una spiccata azione leniti vaantiarrosante. This mixture could be associated with bisabolol in a maximum percentage of 1% to make the ointment also perform a strong soothing vaantiarrosant action.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999BG000061A IT1307903B1 (en) | 1999-12-24 | 1999-12-24 | THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999BG000061A IT1307903B1 (en) | 1999-12-24 | 1999-12-24 | THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITBG990061A0 ITBG990061A0 (en) | 1999-12-24 |
ITBG990061A1 true ITBG990061A1 (en) | 2001-06-25 |
IT1307903B1 IT1307903B1 (en) | 2001-11-19 |
Family
ID=11336751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT1999BG000061A IT1307903B1 (en) | 1999-12-24 | 1999-12-24 | THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1307903B1 (en) |
-
1999
- 1999-12-24 IT IT1999BG000061A patent/IT1307903B1/en active
Also Published As
Publication number | Publication date |
---|---|
ITBG990061A0 (en) | 1999-12-24 |
IT1307903B1 (en) | 2001-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hübner et al. | Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds | |
Marzouk et al. | RETRACTED ARTICLE: Lavender-thymol as a new topical aromatherapy preparation for episiotomy: A randomized clinical trial | |
US7115287B2 (en) | Topical medicament and method of use | |
JPH07330505A (en) | Antimicrobial composition | |
CN102943006B (en) | Essential oil soap with bacterial killing and bacterial inhibiting functions | |
US20040191274A1 (en) | Topical composition | |
JP2001524501A (en) | Antibacterial composition | |
US20180000095A1 (en) | Microbicidal oil-in-water dispersion | |
CN102614113A (en) | Compound washing-free disinfection gel | |
US7438937B2 (en) | Topical burn composition containing Mentha haplocalyx and one or both of Aloe vera and recombinant human epidermal growth factor | |
CN110038039A (en) | A kind of bacteriostatic gel and preparation method | |
EP1230927A1 (en) | Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals | |
ITBG990061A1 (en) | THERAPEUTIC AND ANTISEPTIC ACTION OIL OF THE ANIMAL DERMA, PARTICULARLY IN PODALIC LOCATION. | |
JP2010195706A (en) | New germicidal, fungicidal and moisturizing composition | |
AU2006235798A1 (en) | Topical composition | |
US20040146587A1 (en) | Topical composition for relief of pain and minor skin irritations | |
DE102007002073A1 (en) | Medium for use during care and antimicrobial treatment of skin, for topical dermatological application, and for therapeutic skin and sore treatment, comprises benzalkonium chloride, which is basically exclusive pharmaceutically active | |
US20040185115A1 (en) | Emu oil based methods and compositions for skin ailments | |
JP6455859B2 (en) | Manufacturing method of deodorant and antibacterial agent | |
RU2811227C1 (en) | Antibacterial hand spray | |
RU2786973C1 (en) | Antibacterial hand treatment | |
US9867775B2 (en) | Topical pharmaceutical bases for treating inflammatory disorders | |
RU2759540C1 (en) | Preparation for treatment of bovine finger dermatitis | |
JP6749563B2 (en) | Staphylococcus aureus inhibitor solution, atopic dermatitis treatment solution, cosmetics, cleaning solution and antiseptic solution | |
DE102006032887A1 (en) | Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote skin re-formation or regeneration |